Compare Essex Property Trust, Inc. (ESS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Essex Property Trust, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B), while State Street SPDR S&P Biotech ETF trades at $158.04. The key difference: Essex Property Trust, Inc. pays a 3.93% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Essex Property Trust, Inc. nearer its low. Which is the better fit depends on your goals.
| ESS | XBI | |
|---|---|---|
Market Cap | $18.15B | — |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $298.33 | $164.28 |
52-Week Low | $239.61 | $86.92 |
Enterprise Value | $24.75B | — |
Dividend Yield | 3.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Essex Property Trust, Inc.
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
